LFFLX� | Focused Large Cap Value Fund Class F | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Focused Large Cap Value Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Focused Large Cap Value Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of large U.S. companies.

Fund Basicsas of 08/31/2022

Total Net Assets
$223.04 M
Inception Date
08/01/2019
Dividend Frequency
Annually
Fund Gross Expense Ratio
0.78%
Fund Net Expense Ratio
0.68%
Number of Holdings
36

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -20.68% -15.32% 4.11% - - 3.65%
Lipper Category Avg. Large-Cap Value Funds -17.55% -10.65% 5.30% - - -
Russell 1000® Value Index -17.75% -11.36% 4.36% - - 4.30%

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -20.68% -15.32% 4.11% - - 3.65%
Lipper Category Avg. Large-Cap Value Funds -17.55% -10.65% 5.30% - - -
Russell 1000® Value Index -17.75% -11.36% 4.36% - - 4.30%

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

TEN LARGEST HOLDINGS as of 08/31/2022

Holding Assets
Allstate Corp/The 4.3%
Raytheon Technologies Corp 4.1%
Ameriprise Financial Inc 3.9%
KKR & Co Inc 3.8%
CVS Health Corp 3.7%
Wells Fargo & Co 3.7%
NRG Energy Inc 3.5%
Centene Corp 3.2%
Organon & Co 3.2%
T-Mobile US Inc 3.2%

INVESTMENT TEAM

A. Edward Allinson
John C. Hardy

Portfolio Manager

19 Years of Industry Experience

Jeff Diamond
Jeff Diamond, CFA

Portfolio Manager

35 Years of Industry Experience

John F. Corr
Darnell Azeez

Portfolio Manger

20 Years of Industry Experience

Supported By 34 Investment Professionals with 18 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -20.68% -15.32% 4.11% - - 3.65%
Lipper Category Avg. Large-Cap Value Funds -17.55% -10.65% 5.30% - - -
Russell 1000® Value Index -17.75% -11.36% 4.36% - - 4.30%

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 07/31/2019
w/o sales charge -20.68% -15.32% 4.11% - - 3.65%
Lipper Category Avg. Large-Cap Value Funds -17.55% -10.65% 5.30% - - -
Russell 1000® Value Index -17.75% -11.36% 4.36% - - 4.30%

Fund Expense Ratio :

Gross 0.78%

Net 0.68%

Year Fund Returns Russell 1000® Value Index
2021 28.07% 25.16%
2020 4.87% 2.80%
2019 5.15% 26.54%
Year Q1 Q2 Q3 Q4 Yearly Returns
2022 -1.54% -13.37% -7.00% - -15.99%
2021 14.55% 5.00% -0.27% 6.76% 28.07%
2020 -36.10% 29.04% 2.09% 24.57% 4.87%
2019 - - - 5.92% 5.15%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 6/30/2022

  • The Fund employs a fundamental, bottom-up individual stock selection strategy that focuses on quality companies with compelling valuation over a long term horizon.
  • We initiated a position in T-Mobile US, Inc., an American wireless network operator. The company is nearing completion of the Sprint network integration which should result in a decline in related capital expenditures and operating expenses, and a significant increase in free cash flow. The company intends to repurchase $60 billion of its stock, representing about 35% of current market capitalization, starting in 2023.
  • We also initiated a position in shares of Horizon Therapeutics Plc, a biopharmaceutical company. The company has a unique focus on rare diseases such as thyroid eye disease and uncontrolled gout. We believe the market is undervaluing the potential of the company’s on-market drugs, its research & development pipeline, and the ability of management to successfully execute its strategy.
  • We sold the Fund’s position in Alphabet Inc., a multinational technology company that specializes in Internet-related services and products, in favor of what we consider to be more attractive investment opportunities consistent with our normalized free cash flow methodology.
  • We sold the Fund’s position in Dow, Inc., materials science company, in favor of what we consider to be more attractive investment opportunities consistent with our normalized free cash flow methodology.

PORTFOLIO DETAILS as of 08/31/2022

Total Net Assets
$223.04 M
Number of Holdings
36
Weighted Average Market Cap.
69.5 B
P/B Ratio
2.2x
P/E Ratio
13.5x

Contributors & Detractors as of  06/30/2022

Contributors

Holding Contribution
Pfizer, Inc. 0.1%
T-Mobile US, Inc. 0.0%
Marathon Petroleum Corp. 0.0%
NRG Energy, Inc. 0.0%
Centene Corp. 0.0%

Detractors

Holding Contribution
Caesars Entertainment Inc -1.6%
Ameriprise Financial Inc -0.8%
Alcoa Corporation -0.8%
Fidelity National Financial Group -0.8%
Kkr & Co Inc -0.8%

Attribution Analysis 

Focused Large Cap Value Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Fees & Expenses

Fees & Expenses

Expense Ratioas of 09/30/2022

Fund Gross Expense Ratio Fund Net Expense Ratio
0.78% 0.68%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 1000® Value Index measures the performance of those Russell 1000 companies with lower price-to-book ratios and lower forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field